Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 231

1.

Preliminary validation of the Claudication Symptom Instrument (CSI).

Edwards TC, Lavallee DC, Clowes AW, Devine EB, Flum DR, Meissner MH, Thomason ET, Barbic SP, Beck SJ, Patrick DL.

Vasc Med. 2017 Dec;22(6):482-489. doi: 10.1177/1358863X17731623. Epub 2017 Sep 21.

PMID:
28931345
2.

A single nucleotide polymorphism of cyclin-dependent kinase inhibitor 1B (p27Kip1) associated with human vein graft failure affects growth of human venous adventitial cells but not smooth muscle cells.

Kenagy RD, Kikuchi S, Chen L, Wijelath ES, Stergachis AB, Stamatoyannopoulos J, Tang GL, Clowes AW, Sobel M.

J Vasc Surg. 2018 Jan;67(1):309-317.e7. doi: 10.1016/j.jvs.2016.12.113. Epub 2017 May 16.

3.

Tissue Factor Activity in Dialysis Access Grafts.

Hasenstab D, Kirkman TR, Clowes AW, Kohler TR.

Ann Vasc Surg. 2016 Feb;31:179-85. doi: 10.1016/j.avsg.2015.10.008. Epub 2015 Nov 17.

PMID:
26597243
4.

Scavenger receptor class A member 5 (SCARA5) and suprabasin (SBSN) are hub genes of coexpression network modules associated with peripheral vein graft patency.

Kenagy RD, Civelek M, Kikuchi S, Chen L, Grieff A, Sobel M, Lusis AJ, Clowes AW.

J Vasc Surg. 2016 Jul;64(1):202-209.e6. doi: 10.1016/j.jvs.2014.12.052. Epub 2015 Apr 30.

5.

Surgical marking pen dye inhibits saphenous vein cell proliferation and migration in saphenous vein graft tissue.

Kikuchi S, Kenagy RD, Gao L, Wight TN, Azuma N, Sobel M, Clowes AW.

J Vasc Surg. 2016 Apr;63(4):1044-50. doi: 10.1016/j.jvs.2014.10.017. Epub 2015 Apr 30.

6.

M2 Macrophage Polarization Mediates Anti-inflammatory Effects of Endothelial Nitric Oxide Signaling.

Lee WJ, Tateya S, Cheng AM, Rizzo-DeLeon N, Wang NF, Handa P, Wilson CL, Clowes AW, Sweet IR, Bomsztyk K, Schwartz MW, Kim F.

Diabetes. 2015 Aug;64(8):2836-46. doi: 10.2337/db14-1668. Epub 2015 Apr 6.

7.

Efficient gene transfer and durable transgene expression in grafted rabbit veins.

Du L, Zhang J, Clowes AW, Dichek DA.

Hum Gene Ther. 2015 Jan;26(1):47-58. doi: 10.1089/hum.2014.084.

8.

Vasodilator-stimulated phosphoprotein protects against vascular inflammation and insulin resistance.

Cheng AM, Rizzo-DeLeon N, Wilson CL, Lee WJ, Tateya S, Clowes AW, Schwartz MW, Kim F.

Am J Physiol Endocrinol Metab. 2014 Oct 1;307(7):E571-9. doi: 10.1152/ajpendo.00303.2014. Epub 2014 Aug 12.

9.

Low levels of a natural IgM antibody are associated with vein graft stenosis and failure.

Sobel M, Moreno KI, Yagi M, Kohler TR, Tang GL, Clowes AW, Zhou XH, Eugenio E.

J Vasc Surg. 2013 Oct;58(4):997-1005.e1-2. doi: 10.1016/j.jvs.2013.04.042. Epub 2013 Jul 13.

10.

Vasospasm as a cause for claudication in athletes with external iliac artery endofibrosis.

Shalhub S, Zierler RE, Smith W, Olmsted K, Clowes AW.

J Vasc Surg. 2013 Jul;58(1):105-11. doi: 10.1016/j.jvs.2012.12.060. Epub 2013 Mar 29.

11.

VASP increases hepatic fatty acid oxidation by activating AMPK in mice.

Tateya S, Rizzo-De Leon N, Handa P, Cheng AM, Morgan-Stevenson V, Ogimoto K, Kanter JE, Bornfeldt KE, Daum G, Clowes AW, Chait A, Kim F.

Diabetes. 2013 Jun;62(6):1913-22. doi: 10.2337/db12-0325. Epub 2013 Jan 24.

12.

Smooth muscle cell plasticity: fact or fiction?

Nguyen AT, Gomez D, Bell RD, Campbell JH, Clowes AW, Gabbiani G, Giachelli CM, Parmacek MS, Raines EW, Rusch NJ, Speer MY, Sturek M, Thyberg J, Towler DA, Weiser-Evans MC, Yan C, Miano JM, Owens GK.

Circ Res. 2013 Jan 4;112(1):17-22. doi: 10.1161/CIRCRESAHA.112.281048. Epub 2012 Oct 23. No abstract available.

13.

Inhibition of PDGF-B induction and cell growth by syndecan-1 involves the ubiquitin and SUMO-1 ligase, Topors.

Braun KR, DeWispelaere AM, Bressler SL, Fukai N, Kenagy RD, Chen L, Clowes AW, Kinsella MG.

PLoS One. 2012;7(8):e43701. doi: 10.1371/journal.pone.0043701. Epub 2012 Aug 17.

14.

Endothelial NO/cGMP/VASP signaling attenuates Kupffer cell activation and hepatic insulin resistance induced by high-fat feeding.

Tateya S, Rizzo NO, Handa P, Cheng AM, Morgan-Stevenson V, Daum G, Clowes AW, Morton GJ, Schwartz MW, Kim F.

Diabetes. 2011 Nov;60(11):2792-801. doi: 10.2337/db11-0255. Epub 2011 Sep 12.

15.

Reduced vascular nitric oxide-cGMP signaling contributes to adipose tissue inflammation during high-fat feeding.

Handa P, Tateya S, Rizzo NO, Cheng AM, Morgan-Stevenson V, Han CY, Clowes AW, Daum G, O'Brien KD, Schwartz MW, Chait A, Kim F.

Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2827-35. doi: 10.1161/ATVBAHA.111.236554. Epub 2011 Sep 8.

16.

A link between smooth muscle cell death and extracellular matrix degradation during vascular atrophy.

Kenagy RD, Min SK, Mulvihill E, Clowes AW.

J Vasc Surg. 2011 Jul;54(1):182-191.e24. doi: 10.1016/j.jvs.2010.12.070. Epub 2011 Apr 14.

17.

Aortic length changes during abdominal aortic aneurysm formation, expansion and stabilisation in a rat model.

Michineau S, Dai J, Gervais M, Zidi M, Clowes AW, Becquemin JP, Michel JB, Allaire E.

Eur J Vasc Endovasc Surg. 2010 Oct;40(4):468-74. doi: 10.1016/j.ejvs.2010.05.001. Epub 2010 Jun 15.

18.

VASP phosphorylation at serine239 regulates the effects of NO on smooth muscle cell invasion and contraction of collagen.

Defawe OD, Kim S, Chen L, Huang D, Kenagy RD, Renné T, Walter U, Daum G, Clowes AW.

J Cell Physiol. 2010 Jan;222(1):230-7. doi: 10.1002/jcp.21942.

19.

Syndecan-1: an inhibitor of arterial smooth muscle cell growth and intimal hyperplasia.

Fukai N, Kenagy RD, Chen L, Gao L, Daum G, Clowes AW.

Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1356-62. doi: 10.1161/ATVBAHA.109.190132. Epub 2009 Jul 10.

20.

Cell death-associated ADAMTS4 and versican degradation in vascular tissue.

Kenagy RD, Min SK, Clowes AW, Sandy JD.

J Histochem Cytochem. 2009 Sep;57(9):889-97. doi: 10.1369/jhc.2009.953901. Epub 2009 Jun 8.

Supplemental Content

Loading ...
Support Center